Sanjose, CA USA, Feb 08, 2020 (Wired Release) – Credence Research – The market for cardiac biomarker diagnostic kits was estimated at US$ 2,106.4 million in 2018, with CAGR expected to grow by 5.3 per cent during the forecast period from 2019 to 2027. The global market for cardiac biomarker diagnostic kits has grown competently from 2019 to 2027 due to an increase in the prevalence of cardiac diseases and other lifestyle diseases in the geriatric population. Increased FDA clearance of new cardiac diagnostic kits along with automated systems will enhance overall market growth in the diagnostics industry. New technology expansion, acquisitions and the launch of new products will drive the market in developed countries around the world. Cardiac biomarker diagnostic kits further categorized into product types, disease indication and testing. Angina pectoris in the disease indication show huge opportunity globally.
Access the sample copy of this research report: https://www.credenceresearch.com/sample-request/60172
[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction to the Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also included]
The launch of ultra-sensitive cardiac troponin-I kits and assays, along with improved clinical outcomes, will generate maximum revenue share worldwide. The enhanced guidelines for the production of diagnostic kits will improve overall production. The high prevalence of atherosclerotic vascular disease will have an enormous impact on the global scale. According to WHO data, more than 30% of the mortality rate is due to the CVD. In addition, according to the American Heart Association, total direct medical expenditure on cardiovascular disease is estimated to increase by more than $700 billion in 2035 in the 2016 study. More than 500,000 new cases of angina pectoris have been registered every year in the U.S., henceforth driving market growth in the North American region.
Browse Full Report Originally Published by Credence Research at: https://www.credenceresearch.com/report/cardiac-biomarker-diagnostic-kits-market
Geographic Coverage
North America Cardiac Biomarker Diagnostic Kits Market Revenue and Forecast
Europe Cardiac Biomarker Diagnostic Kits Market Revenue and Forecast
Asia Pacific Cardiac Biomarker Diagnostic Kits Market Revenue and Forecast
Latin America Cardiac Biomarker Diagnostic Kits Market Revenue and Forecast
Middle East and Africa Cardiac Biomarker Diagnostic Kits Market Revenue and Forecast
List of Companies Covered:
bioMerieux SA
Danaher Corporation
Guangzhou Wondfo Biotech Co., Ltd
Siemens AG
Abbott Laboratories
Alere, Inc.
LSI Medience Corporation
Randox laboratories
Ortho Clinical Diagnostics
Hoffmann-La Roche AG
Thermofisher Scientific
Bio-Rad Laboratories
Access the sample copy of this research report: https://www.credenceresearch.com/sample-request/60172
Key questions answered in this report
What are the current market trends and dynamics in the cardiac biomarker diagnostic kits market and valuable opportunities for emerging players?
Which segment accounts for the fastest CAGR during the forecast period and why?
Which product type segment holds a larger market share and why?
Are low and middle-income economies investing in the cardiac biomarker diagnostic kits market?
What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.credenceresearch.com/sample-request/60172
ToC:
Access the sample copy of this research report: https://www.credenceresearch.com/sample-request/60172
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Email: sales@credenceresearch.com
Social Reach Credence Research: Twitter, LinkedIn, Facebook
This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.
from WiredRelease https://ift.tt/38dWwBO
via gqrds
No comments:
Post a Comment